PAR 5.88% 24.0¢ paradigm biopharmaceuticals limited..

Ann: Preliminary Results from Phase 2 MPS I Study, page-16

  1. 478 Posts.
    lightbulb Created with Sketch. 130
    I personally think the results were understated although they weren't shouting from the hilltops about Lazarus type results they still had improvements for people that have virtually no treatment. So some improvement is encouraging but the proof of the pudding will be in a years time when joints and bones have healed a little bit then you can truly ascertain how big of an improvement is made and also stem cell may also play a part of the treatment in conjunction with zilosul.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
-0.015(5.88%)
Mkt cap ! $84.05M
Open High Low Value Volume
25.5¢ 26.5¢ 24.0¢ $167.2K 671.5K

Buyers (Bids)

No. Vol. Price($)
3 108741 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
25.5¢ 9700 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.